Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enphase Energy Inc (ENPH) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance

Enphase Energy IncTrade
Iovance Biotherapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Enphase Energy Inc vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Enphase Energy Inc trades at $32.74 (market cap $4.35B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.59 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is the larger of the two by market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Enphase Energy Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.

ENPHIOVA
Market Cap
$4.35B$6.04B
Volume
5,068,59514,805,993
Sector
EnergyHealth
52-Week High
$72.33$14.82
52-Week Low
$26.12$1.81
Typical Hold Time
72 Days0 Days
Enterprise Value
$3.99B$5.97B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enphase Energy Inc

Enphase Energy (ENPH) trades at $32.095, down 4.19% with bearish technical signals. The stock shows mixed fundamentals with revenue declining from $2.3B in 2023 to $1.47B in 2025, though net income margin improved to 11.68%. Recent earnings show two misses in the last three quarters. Analyst sentiment is divided with 42% buy ratings but a consensus price target of $42.90 suggesting 34% upside. The company continues innovation with IQ Meter Collar approvals and solid-state transformer development for AI data centers.

The stock faces headwinds from solar industry pressures and elevated borrowing costs, but maintains strong gross margins and product innovation. With current price near support at $32 and significant upside to analyst targets, ENPH presents a contrarian opportunity for investors believing in the long-term solar growth story despite near-term volatility.

Iovance Biotherapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ENPH
100% Buy0% Sell
Avg holding period · 72 Days
IOVA
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Enphase Energy Inc

Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.

Read more on ENPH →

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →